198 related articles for article (PubMed ID: 26970596)
1. HPLC method development, validation, and impurity characterization of a potent antitumor indenoisoquinoline, LMP776 (NSC 725776).
Wang J; Liu M; Yang C; Wu X; Wang E; Liu P
J Pharm Biomed Anal; 2016 May; 124():267-273. PubMed ID: 26970596
[TBL] [Abstract][Full Text] [Related]
2. HPLC method development, validation, and impurity characterization of a potent antitumor nucleoside, T-dCyd (NSC 764276).
Liu M; Wang J; Liu P
J Pharm Biomed Anal; 2016 Nov; 131():429-435. PubMed ID: 27661436
[TBL] [Abstract][Full Text] [Related]
3. HPLC method development, validation and impurity characterization for an antitumor Hsp90 inhibitor-PU-H71 (NSC 750424).
Liu M; Wang J; Wu X; Wang E; Baptista D; Scott B; Liu P
J Pharm Biomed Anal; 2014 Feb; 89():34-41. PubMed ID: 24252723
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
5. Use of the hyphenated LC-MS/MS technique and NMR/IR spectroscopy for the identification of exemestane stress degradation products during the drug development.
Stolarczyk EU; Rosa A; Kubiszewski M; Zagrodzka J; Cybulski M; Kaczmarek Ł
Eur J Pharm Sci; 2017 Nov; 109():389-401. PubMed ID: 28865686
[TBL] [Abstract][Full Text] [Related]
6. Impurity profiling and stability-indicating method development and validation for the estimation of assay and degradation impurities of midostaurin in softgel capsules using HPLC and LC-MS.
Lakka NS; Kuppan C; Ravinathan P
Biomed Chromatogr; 2021 Dec; 35(12):e5222. PubMed ID: 34331472
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of Prothionamide degradation impurities by mass spectrometry, NMR spectroscopy, and ultra high performance liquid chromatography method development.
Baksam VK; Saritha N; Mohan SK; Shandilya S; Kumar P
J Sep Sci; 2021 May; 44(10):2078-2088. PubMed ID: 33733566
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a stability indicating assay of doxofylline by RP-HPLC: ESI-MS/MS, ¹H and ¹³C NMR spectroscopic characterization of degradation products and process related impurities.
Rao RN; Naidu ChG; Prasad KG; Santhakumar B; Saida S
J Pharm Biomed Anal; 2013 May; 78-79():92-9. PubMed ID: 23466440
[TBL] [Abstract][Full Text] [Related]
9. Selective separation and characterisation of stress degradation products and process impurities of prucalopride succinate by LC-QTOF-MS/MS.
Mahamuni BS; Jajula A; Awasthi A; Kalariya PD; Talluri MV
J Pharm Biomed Anal; 2016 Jun; 125():219-28. PubMed ID: 27037978
[TBL] [Abstract][Full Text] [Related]
10. RP-LC Method Development and Validation for Dasatinib Forced Degradation Study: Isolation and Structural Characterization by NMR and HRMS.
Kavitapu DR; Murty JNSRC; Maruthapillai A; Senadi GC; Mahapatra S
J Chromatogr Sci; 2024 Apr; 62(4):347-355. PubMed ID: 37340779
[TBL] [Abstract][Full Text] [Related]
11. Forced degradation study of baricitinib and structural characterization of its degradation impurities by high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy.
Chaganti S; Dhiman V; Madhyanapu Golla V; K R R; Khemchandani R; Samanthula G
Rapid Commun Mass Spectrom; 2023 Sep; 37(18):e9605. PubMed ID: 37580847
[TBL] [Abstract][Full Text] [Related]
12. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
[TBL] [Abstract][Full Text] [Related]
13. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
[TBL] [Abstract][Full Text] [Related]
14. Characterization, HPLC method development and impurity identification for 3,4,3-LI(1,2-HOPO), a potent actinide chelator for radionuclide decorporation.
Liu M; Wang J; Wu X; Wang E; Abergel RJ; Shuh DK; Raymond KN; Liu P
J Pharm Biomed Anal; 2015 Jan; 102():443-9. PubMed ID: 25459944
[TBL] [Abstract][Full Text] [Related]
15. Degradation pathways and impurity profiling of the anticancer drug apalutamide by HPLC and LC-MS/MS and separation of impurities using Design of Experiments.
Lakka NS; Kuppan C; Vadagam N; Reddamoni SY; Muthusamy C
Biomed Chromatogr; 2023 Feb; 37(2):e5549. PubMed ID: 36409057
[TBL] [Abstract][Full Text] [Related]
16. Isolation, Characterization, and Toxicity Study of Stress Degradation Products of Pranlukast Hydrate.
Prajapati KJ; Kothari CS
Chem Res Toxicol; 2022 Jul; 35(7):1206-1219. PubMed ID: 35731702
[TBL] [Abstract][Full Text] [Related]
17. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
Kumar N; Sangeetha D; Reddy SP
J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
[TBL] [Abstract][Full Text] [Related]
18. Forced degradation and impurity profiling: recent trends in analytical perspectives.
Jain D; Basniwal PK
J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
[TBL] [Abstract][Full Text] [Related]
19. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
20. Reversed-phase liquid chromatography with electrospray mass detection and 1H and 13C NMR characterization of new process-related impurities, including forced degradants of efavirenz: related substances correlated to the synthetic pathway.
Gadapayale K; Kakde R; Sarma VU
J Sep Sci; 2015 Jan; 38(2):218-30. PubMed ID: 25385054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
